Similar articles

• Balancing the benefits and harms of low-dose computed tomography screening for lung cancer: Medicare's options for coverage.

  Wiener RS. Wiener RS. Ann Intern Med. 2014 Sep 16;161(6):445-6. doi: 10.7326/M14-1352. Ann Intern Med. 2014. PMID: 24957566 No abstract available.
• Summaries for patients. Screening for lung cancer: recommendations from the U.S. Preventive Services Task Force.

  [No authors listed] [No authors listed] Ann Intern Med. 2014 Mar 4;160(5):I-40. doi: 10.7326/P14-9009. Ann Intern Med. 2014. PMID: 24378963 No abstract available.
• Overdiagnosis in lung cancer screening: why modelling is essential.

  Ten Haaf K, de Koning HJ. Ten Haaf K, et al. J Epidemiol Community Health. 2015 Nov;69(11):1035-9. doi: 10.1136/jech-2014-204079. Epub 2015 Jun 12. J Epidemiol Community Health. 2015. PMID: 26071497 Free PMC article. No abstract available.
• Elements of a Lung Cancer Screening Program.

  Fintelmann FJ. Fintelmann FJ. Semin Roentgenol. 2017 Jul;52(3):129-131. doi: 10.1053/j.ro.2017.06.004. Epub 2017 Jun 5. Semin Roentgenol. 2017. PMID: 28734393 Review. No abstract available.
• Lung Computed Tomography Screening Reporting and Data System Version 1.0.

  Carter BW, Lichtenberger JP 3rd, Shroff GS, Wu CC. Carter BW, et al. Semin Roentgenol. 2017 Jul;52(3):137-142. doi: 10.1053/j.ro.2017.06.009. Epub 2017 Jun 5. Semin Roentgenol. 2017. PMID: 28734395 Review. No abstract available.